Delivery Order SPE2DB24D2212-SPE2DB25FHQRN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors on August 28, 2025, with a ceiling value of $5,441.80. This non-competitive delivery order, valued at firm fixed price, is set to be completed by August 29, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a single delivery transaction under the company's existing contract vehicle with the DLA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections, with a ceiling value of $3,728.87. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a contract value of $4,568.72. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order falls under...
- The Defense Logistics Agency awarded a $1,360.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injections on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract, which carries no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $1,994.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This competitive award, with no set-aside designation, is scheduled for completion by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $3,521.86 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This non-set-aside, firm fixed-price contract is scheduled for completion by August 14, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mounjaro 2.5 mg/0.5 ml pen injectors with a contract ceiling value of $3,189.61. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,904.63 delivery order contract to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors with a completion date of August 19, 2025. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing as the pricing mechanism. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $4,358.90 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pen injectors on August 19, 2025. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a $1,017.21 delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen injectors, with completion scheduled for August 21, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The vendor, headquartered in Conshohocken, Pennsylvania, serves as a major...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQRNDelivery Order
The Defense Logistics Agency awarded a $3,874.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mounjaro 12.5 mg/0.5 ml pen injectors in 0.5 ml quantities. This is a competitive award with no set-aside designation, with performance to be completed by August 29, 2025, at the contractor's facility in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen Drug Corp's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle running through December 2026. The parent contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs and other federal healthcare systems worldwide. Mounjaro, a diabetes medication, aligns with the therapeutic scope of the prime vendor contract, which encompasses specialty medications, brand-name drugs, and related medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/28/25 |